Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 155.17% vs -28.34% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 107.55% vs -249.54% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.81% vs 68.45% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 63.59% vs -5,425.72% in Mar 2024
Compare Profit and Loss Results of Parmax Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
28.00
30.00
-2.00
-6.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
28.00
30.00
-2.00
-6.67%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
21.00
20.00
1.00
5.00%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
2.00
6.00
-4.00
-66.67%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
27.00
33.00
-6.00
-18.18%
Operating Profit (PBDIT) excl Other Income
0.00
-3.00
3.00
100.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
-2.00
2.00
100.00%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
0.00
-4.00
4.00
100.00%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
-1.00
-7.00
6.00
85.71%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-2.00
-19.00
17.00
89.47%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-2.00
-19.00
17.00
89.47%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-4.00
1.00
-5.00
-500.00%
Profit Available for appropriations
-6.00
-18.00
12.00
66.67%
Appropriations
-6.00
-18.00
12.00
66.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-5.6
-7.86
2.26
28.75%
Profit And Loss - Net Sales
Net Sales 28.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 155.17% vs -28.34% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 107.55% vs -249.54% in Mar 2024
Profit And Loss - Interest
Interest 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.81% vs 68.45% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -2.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 63.59% vs -5,425.72% in Mar 2024






